The article “Preventive Counseling, Screening, and Therapy for the Patient with Newly Diagnosed HIV Infection” (January 15, 2006, page 271) contained an error in the last recommendation of the “SORT: Key Recommendations for Practice” table regarding the CD4+ cell counts at which antibiotic prophylaxis for toxoplasmosis and Mycobacterium avium-intracellulare complex should be initiated (the cutoffs were inadvertently transposed). The recommendation should have read as follows: “Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively.” The online version of this article has been corrected and the corrected SORT table appears below.
SORT: KEY RECOMMENDATIONS FOR PRACTICE
| Clinical recommendation | Evidence rating | References |
|---|---|---|
| Patients with HIV should be monitored for CD4+ lymphocyte and HIV RNA levels every three to six months. | C | 7, 8, 26, 28 |
| Patients who are hepatitis A or B nonimmune at baseline should be vaccinated. | B | 7, 8, 25 |
| Tuberculosis prophylaxis should be given to patients with any of the following: history or symptoms of tuberculosis, a PPD of at least 5 mm, or a possible false-negative PPD. | C | 7, 8, 25 |
| Pneumocystis jiroveci prophylaxis with trimethoprim/sulfamethoxazole (Bactrim, Septra) should be initiated at CD4+ counts of less than 200 cells per mm3. | A | 7, 8, 25 |
| Women with HIV should have Pap smears every six months for the first year and, if normal, annual Pap smears thereafter. | C | 7, 8, 25 |
| High-risk patients with ongoing exposure should be checked annually for gonorrhea, chlamydia, syphilis, and hepatitis C. | C | 7, 8, 25 |
| Antibiotic prophylaxis should be used to prevent toxoplasmosis and Mycobacterium avium-intracellulare complex infection at CD4+ cell counts below 100 and below 50 cells per mm3, respectively. | B | 7, 8, 25 |
HIV = human immunodeficiency virus; PPD = purified protein derivative; Pap = Papanicolaou.
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, seehttps://www.aafp.org/afpsort.xml.
